ArticleLancet (London, England)2020
Safety and efficacy of the Russian COVID-19 vaccine: more information needed.
Article in Lancet (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Gam-COVID-Vac, EpiVacCorona, and CoviVac effectiveness against lung injury during Delta and Omicron variant surges in St. Petersburg, Russia: a test-negative case-control study.Respiratory research · 2022Trial
- Article
- Recent Update of COVID-19 Vaccines.Advanced pharmaceutical bulletin · 2022Review
- Article
- Article
- Controversy surrounding the Sputnik V vaccine.Respiratory medicine · 2021Review
- Review
- Roles of existing drug and drug targets for COVID-19 management.Metabolism open · 2021Article
- The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review.Medicine in drug discovery · 2021Review
- Ethnic and minority group differences in engagement with COVID-19 vaccination programmes - at Pandemic Pace; when vaccine confidence in mass rollout meets local vaccine hesitancy.Israel journal of health policy research · 2021Article
- Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial.Lancet (London, England) · 2021Article
- Effectiveness of potential antiviral treatments in COVID-19 transmission control: a modelling study.Infectious diseases of poverty · 2021Article
- The Perception and Attitudes toward COVID-19 Vaccines: A Cross-Sectional Study in Poland.Vaccines · 2021Article
- Willingness to Receive COVID-19 Vaccination in Japan.Vaccines · 2021Article
- Current State of the First COVID-19 Vaccines.Vaccines · 2021Review
- Attitudes to Being Vaccinated Against COVID-19: A Survey of People With Epilepsy in China.Frontiers in neurology · 2021Article
- COVID-19: State of the Vaccination.Drugs & therapy perspectives : for rational drug selection and use · 2021Review
- Concern About the Adverse Effects of Thrombocytopenia and Thrombosis After Adenovirus-Vectored COVID-19 Vaccination.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/HemostasisReview
- COVID-19 Pandemic-Frontline Experiences and Lessons Learned From a Tertiary Care Teaching Hospital at a Suburban Location of Southeastern India.Frontiers in public healthArticle
Corrections and comments
- Comment on
Authors and funding
16 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.